EE9600142A - Helicobacter spp. vastased asoloonide derivaadid, nende valmistamise meetod ja kasutamine, vaheühendid, farmatseutiline kompositsioon ja selle valmistamise meetod ning terapeutiline kombinatsioon. - Google Patents
Helicobacter spp. vastased asoloonide derivaadid, nende valmistamise meetod ja kasutamine, vaheühendid, farmatseutiline kompositsioon ja selle valmistamise meetod ning terapeutiline kombinatsioon.Info
- Publication number
- EE9600142A EE9600142A EE9600142A EE9600142A EE9600142A EE 9600142 A EE9600142 A EE 9600142A EE 9600142 A EE9600142 A EE 9600142A EE 9600142 A EE9600142 A EE 9600142A EE 9600142 A EE9600142 A EE 9600142A
- Authority
- EE
- Estonia
- Prior art keywords
- image
- pct
- 4alkyl
- 6alkyl
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94200938 | 1994-04-06 | ||
| PCT/EP1995/001184 WO1995027704A1 (en) | 1994-04-06 | 1995-03-29 | Anti-helicobacter ester and carbamate derivatives of azolones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9600142A true EE9600142A (et) | 1997-04-15 |
Family
ID=8216773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9600142A EE9600142A (et) | 1994-04-06 | 1995-03-29 | Helicobacter spp. vastased asoloonide derivaadid, nende valmistamise meetod ja kasutamine, vaheühendid, farmatseutiline kompositsioon ja selle valmistamise meetod ning terapeutiline kombinatsioon. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5710156A (et) |
| EP (1) | EP0754180B1 (et) |
| JP (1) | JPH09511513A (et) |
| CN (1) | CN1145067A (et) |
| AT (1) | ATE207910T1 (et) |
| AU (1) | AU685935B2 (et) |
| BR (1) | BR9507289A (et) |
| CA (1) | CA2185552A1 (et) |
| CZ (1) | CZ287596A3 (et) |
| DE (1) | DE69523581T2 (et) |
| EE (1) | EE9600142A (et) |
| FI (1) | FI963995A (et) |
| HU (1) | HUT76287A (et) |
| IL (1) | IL113254A (et) |
| NO (1) | NO964216L (et) |
| NZ (1) | NZ283346A (et) |
| PL (1) | PL316655A1 (et) |
| SK (1) | SK127196A3 (et) |
| WO (1) | WO1995027704A1 (et) |
| ZA (1) | ZA952810B (et) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
| US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
| US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
| US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| US5250528A (en) * | 1989-08-02 | 1993-10-05 | Fujisawa Pharmaceutical Co., Ltd. | New aminopiperazine derivatives |
| CA2076257A1 (en) * | 1991-09-13 | 1993-03-14 | Jan Heeres | 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives |
| US5202346A (en) * | 1992-02-25 | 1993-04-13 | American Home Products Corporation | Piperidinyl and piperazinyl derivatives |
| TW279864B (et) * | 1993-02-19 | 1996-07-01 | Janssen Pharmaceutica Nv |
-
1995
- 1995-03-29 US US08/716,397 patent/US5710156A/en not_active Expired - Fee Related
- 1995-03-29 EP EP95914329A patent/EP0754180B1/en not_active Expired - Lifetime
- 1995-03-29 JP JP7526047A patent/JPH09511513A/ja not_active Ceased
- 1995-03-29 NZ NZ283346A patent/NZ283346A/en unknown
- 1995-03-29 SK SK1271-96A patent/SK127196A3/sk unknown
- 1995-03-29 WO PCT/EP1995/001184 patent/WO1995027704A1/en active IP Right Grant
- 1995-03-29 CZ CZ962875A patent/CZ287596A3/cs unknown
- 1995-03-29 AU AU21371/95A patent/AU685935B2/en not_active Ceased
- 1995-03-29 HU HU9602725A patent/HUT76287A/hu unknown
- 1995-03-29 EE EE9600142A patent/EE9600142A/et unknown
- 1995-03-29 BR BR9507289A patent/BR9507289A/pt not_active Application Discontinuation
- 1995-03-29 CN CN95192436A patent/CN1145067A/zh active Pending
- 1995-03-29 AT AT95914329T patent/ATE207910T1/de not_active IP Right Cessation
- 1995-03-29 DE DE69523581T patent/DE69523581T2/de not_active Expired - Fee Related
- 1995-03-29 PL PL95316655A patent/PL316655A1/xx unknown
- 1995-03-29 CA CA002185552A patent/CA2185552A1/en not_active Abandoned
- 1995-04-05 ZA ZA952810A patent/ZA952810B/xx unknown
- 1995-04-05 IL IL11325495A patent/IL113254A/xx not_active IP Right Cessation
-
1996
- 1996-10-04 FI FI963995A patent/FI963995A/fi unknown
- 1996-10-04 NO NO964216A patent/NO964216L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU685935B2 (en) | 1998-01-29 |
| JPH09511513A (ja) | 1997-11-18 |
| CA2185552A1 (en) | 1995-10-19 |
| ATE207910T1 (de) | 2001-11-15 |
| DE69523581T2 (de) | 2002-07-11 |
| SK127196A3 (en) | 1997-05-07 |
| NO964216D0 (no) | 1996-10-04 |
| AU2137195A (en) | 1995-10-30 |
| CN1145067A (zh) | 1997-03-12 |
| DE69523581D1 (de) | 2001-12-06 |
| FI963995A0 (fi) | 1996-10-04 |
| PL316655A1 (en) | 1997-02-03 |
| EP0754180A1 (en) | 1997-01-22 |
| BR9507289A (pt) | 1997-09-23 |
| EP0754180B1 (en) | 2001-10-31 |
| ZA952810B (en) | 1996-10-07 |
| HUT76287A (en) | 1997-07-28 |
| NZ283346A (en) | 1997-05-26 |
| NO964216L (no) | 1996-10-04 |
| IL113254A0 (en) | 1995-07-31 |
| CZ287596A3 (en) | 1997-01-15 |
| IL113254A (en) | 1999-03-12 |
| FI963995A (fi) | 1996-10-04 |
| US5710156A (en) | 1998-01-20 |
| MX9604610A (es) | 1997-11-29 |
| WO1995027704A1 (en) | 1995-10-19 |
| HU9602725D0 (en) | 1996-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL114537A (en) | Sulfonamide derivatives of azolones their preparation and pharmaceutical compositions containing them | |
| AP2000001860A0 (en) | Hypolipidemic benzothiazepine compounds. | |
| DK0778834T3 (da) | Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2 | |
| EE9600142A (et) | Helicobacter spp. vastased asoloonide derivaadid, nende valmistamise meetod ja kasutamine, vaheühendid, farmatseutiline kompositsioon ja selle valmistamise meetod ning terapeutiline kombinatsioon. | |
| BR9507677A (pt) | Composto composição farmacéutica processo para a profilaxia ou para o tratamento de condições associadas à inflamação à artrite ou à dor em um mamifero uso do composto processo para a preparação do composto e novo intermediário | |
| FI952458A0 (fi) | Dimetyylibentsofuraanien ja dimetyylibentsopyraanien käyttö 5-HT3-antagonisteina | |
| EG16546A (en) | Therapeutic agents | |
| MY131690A (en) | 6-[triazolyl[3-(trifluoromethyl) phenyl]methyl]-2- quinolinones and -quinolinethiones | |
| DE2966809D1 (en) | 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them | |
| DE3569111D1 (en) | Derivatives of n-(2-pyrrolidinylmethyl)-benzamide, process for their preparation, intermediates and a pharmaceutical preparation |